Acute transverse myelopathy probably related to intravenous gemcitabine plus cisplatin

Annals of Pharmacotherapy

Volumn 45, Issue 4, 2011, Pages 544-545

  Li, Bin ^a   Li, Jing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; RECOMBINANT THROMBOPOIETIN;

ACUTE TRANSVERSE MYELOPATHY; ADULT; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HUMAN; HYDRATION; LETTER; LUNG CANCER; MALE; MULTIPLE CYCLE TREATMENT; NEUROLOGIC EXAMINATION; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPINAL CORD DISEASE; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DEOXYCYTIDINE; HUMANS; INJECTIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MYELITIS, TRANSVERSE; NEOPLASMS, SQUAMOUS CELL;

EID: 79955555320     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P674     Document Type: Letter

References (11)

1. Barstis JL, Black AC. Myelopathy after radiation therapy and chemotherapy with capecitabine and gemcitabine. Cancer Invest 2005;23:596-8.
2. Kwon EJ, Kim SW, Kim KK, et al. A case of gemcitabine and cisplatin associated posterior reversible encephalopathy syndrome. Cancer Res Treat 2009;41:53-5.
3. Takahiro Maeda, Eiji Kikuchi, Kazuhiro Matsumoto, et al. Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient. Int J Clin Oncol 2010;15: 508-11.
4. Tatjana PS, Martina GS, Martin P, et al. Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med 2008;40: 665-71.
5. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
6. Baker WJ, Royer GL Jr, Weiss RB. Cytarabine and neurologic toxicity. J Clin Oncol 1991;9:679-93.
7. Saito B, Nakamaki T, Nakashima H, et al. Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia. Am J Hematol 2007;82:304-6.
8. Wang MY, Arnold AC, Vinters HV, et al. Bilateral blindness and lumbosacral myelopathy associated with high-dose carmustine and cisplatin therapy. Am J Ophthalmol 2000;130:367-8.
9. Takeda S, Yamazaki K, Miyakawa T, et al. Progressive multifocal leukoencephalopathy showing extensive spinal cord involvement in a patient with lymphocytopenia. Neuropathology 2009;29:485-93.
10. Nomura K, Ohno R, Hamaguc K, et al. Clinicopathological report of cisplatin encephalopathy. Rinsho Shinkeigaku 1995;35:64-9.
11. Larsen FO, Hansen SW. Severe neurotoxicity caused by gemcitabine treatment. Acta Oncol 2004;43:590-1.